Gamma Medica
Signal active
Organization
Contact Information
Overview
Gamma Medica, Inc. is proud to offer the LumaGEM® MBI System. As the first commercially available, FDA cleared, planar, dual head, fully solid state digital imaging system utilizing cadmium zinc telluride (CZT) technology used for breast imaging, LumaGEM is able to detect millimeter-size breast cancers missed by mammography, especially in women with dense breast tissue.
About
Industries
Biotechnology, Health Care, Pharmaceutical
Founded
2013
Employees
11-50
Headquarters locations
United States, North America
Social
N/A
Profile Resume
Gamma Medica headquartered in United States, North America, operates in the Biotechnology, Health Care, Pharmaceutical sector. The company focuses on Biotechnology and has secured $990.0M in funding across 36 round(s). With a team of 11-50 employees, Gamma Medica is actively contributing to advancements in Biotechnology. Their latest funding round, Series A - Gamma Medica, raised $16.0M. Discover more about their projects, partnerships, and impact on our platform.
Employees
N/A
Funding Rounds
Funding rounds
3
Investors
1
Lead Investors
0
Total Funding Amount
$27.5M
Details
2
Gamma Medica has raised a total of $27.5M in funding over 2 rounds.
| Announcement date | Transaction name | Number of Investors | Money raised | Lead Investor |
|---|---|---|---|---|
| 2014 | Early Stage Venture | 5.0M | ||
| 2013 | Early Stage Venture | 16.0M |
Investors
Gamma Medica is funded by 4 investors.
| Investor Name | Lead Investor | Funding Round | Partners |
|---|---|---|---|
| Gamma Medica | - | FUNDING ROUND - Gamma Medica | 6.5M |
| Hercules Capital | - | FUNDING ROUND - Hercules Capital | 6.5M |
| Gamma Medica | - | FUNDING ROUND - Gamma Medica | 5.0M |
| Hercules Capital | - | FUNDING ROUND - Hercules Capital | 5.0M |
Recent Activity
There is no recent news or activity for this profile.